Home » Entries posted by Soujanya Ravi
Entries posted by soujanyaravi
Boston Scientific to take full ownership of Preventice Solutions

Boston Scientific to take full ownership of Preventice Solutions

Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values 100% of the latter at up to $1.25 billion. The consideration includes $925 million in upfront cash payment and an additional payment of up to $300m based […]

Philips to acquire medical device integration firm Capsule Technologies for $635m

Dutch health technology company Royal Philips has signed an all-cash deal worth $635 million to acquire Capsule Technologies, a portfolio company of Francisco Partners. Based in Massachusetts, Capsule Technologies caters to hospitals and healthcare organizations with medical device integration (MDI) and data technologies. Established in 1997, the company is said to serve more than 2,800 […]

Continue reading …
Hillrom to acquire CAM patch developer Bardy Diagnostics for $375m

Chicago-based medical technology company Hillrom is acquiring Bardy Diagnostics (BardyDx), a digital health and ambulatory cardiac monitoring technologies provider, for $375 million. Bardy Diagnostics will also be eligible to receive possible payments in the future based on the meeting of certain commercial milestones. Additionally, Hillrom will acquire the net operating losses of Bardy Diagnostics, valued […]

Continue reading …
ADB grants loan to Jointown Pharmaceutical for expanding pharma distribution network in China

The Asian Development Bank (ADB) has agreed to provide a loan of up to €30 million ($37 million) to Jointown Pharmaceutical Group for expanding pharmaceutical distribution facilities in the China (PRC). The loan will be used towards the construction and expansion of Jointown Pharmaceutical’s pharma distribution facilities in Haikou, Tangshan, and Nanjing. The three facilities […]

Continue reading …
Teleflex to acquire hemostatic devices manufacturer Z-Medica

Teleflex, a Pennsylvania-based healthcare supplies and services provider, has agreed to acquire hemostatic devices manufacturer Z-Medica, in a deal worth up to $525 million. Based in Connecticut, Z-Medica is a portfolio company of Linden Capital Partners. The company is engaged in developing and commercializing hemorrhage control products. Its three main hemostatic device brands are QuikClot, […]

Continue reading …
Lab established in Liverpool to study how novel coronavirus affects people

The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool, the Imperial College London, and the University of Edinburgh to handle the coronavirus outbreak from the government’s rapid response call. This investment in Urgent Public Health Research is necessary to understand COVID-19 as well as its impact on the human […]

Continue reading …
behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal

behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects the ‘instant triage’ to enable an expedited diagnosis of novel coronavirus cases and ensure resources are properly allocated. According to behold.ai, its red dot algorithm was trained […]

Continue reading …
RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford

RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial. The RECOVERY clinical trial, which has enrolled the first patients, will test the effects of potential drug treatments for COVID-19 patients admitted to hospitals. The objective of the clinical […]

Continue reading …
COVID-19 Genomics UK Consortium to map COVID-19 spread

A new COVID-19 Genomics UK Consortium has been created with support from the UK government to map how the novel coronavirus spreads and behaves by using whole-genome sequencing. The University of Liverpool is the newest member to join the consortium which is said to include the UK’s leading clinicians and scientists. The consortium backed by […]

Continue reading …
Thermo Fisher to acquire Qiagen to expand specialty diagnostics portfolio

Thermo Fisher acquisition of Qiagen : US life sciences company Thermo Fisher Scientific has agreed to acquire Qiagen, a Netherlands-based provider of molecular diagnostics and sample preparation technologies in an all-cash deal worth around $11.5 billion. The deal includes the assumption of nearly Qiagen’s $1.4 billion of net debt by the US firm. Thermo Fisher […]

Continue reading …
Page 1 of 212